Elvie sells MAA 71.37: Dissolvable oral film for migraines works well in trial to support application for EU approval
The trial compared VersaFilm with the European reference drug Maxalt lingua, marketed in Germany by Merck Sharp & Dohme, to support the planned filing of a Marketing Authorisation Application (MAA) with the ... in US Merck & Co's (NYSE:MRK) Maxalt. ...
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home